Skip to main content
. Author manuscript; available in PMC: 2018 May 24.
Published in final edited form as: JAMA Neurol. 2016 Aug 1;73(8):934–943. doi: 10.1001/jamaneurol.2016.1017

Table 3.

Cerebral microbleeds and decline in specific cognitive domains

G-factor Executive functions Information processing Memory Motor Speed

Model I

Lobar* −0.02 (−0.09;0.05) −0.03(−0.10;0.04) −0.03 (−0.10;0.04) −0.02 (−0.11;0.08) −0.05 (−0.16;0.06)
 Single 0.0003 (−0.08;0.08) −0.02 (−0.08;0.05) −0.001 (−0.07;0.06) 0.01 (−0.08;0.10) −0.03 (−0.16;0.09)
 2–4 CMBs −0.01 (−0.15;0.13) 0.02 (−0.09;0.13) 0.01 (−0.11;0.12) −0.02 (−0.17;0.14) −0.11 (−0.32;0.11)
 >4 CMBs −0.37 (−0.65;−0.09) −0.31 (−0.51;−0.11) −0.44 (−0.65;−0.22) −0.34 (−0.64;−0.03) −0.09 (−0.50;0.33)

Deep or infratentorial± −0.02 (−0.13;0.10) −0.03 (−0.14;0.08) 0.01 (−0.11;0.13) 0.02 (−0.13;0.17) 0.03 (−0.15;0.20)
 Single CMB 0.03 (−0.11;0.18) 0.02 (−0.09;0.12) 0.06 (−0.06;0.17) −0.02 (−0.18;0.14) 0.10 (−0.13;0.32)
 2–4 CMBs 0.06 (−0.17;0.29) −0.03 (−0.21;0.14) 0.05 (−0.14;0.24) 0.21 (−0.05;0.47) 0.26 (−0.10;0.63)
 >4 CMBs −0.34 (−0.62;−0.05) −0.20 (−0.41;0.02) −0.26 (−0.50;−0.03) −0.13 (−0.44;0.19) −0.61 (s;1.05;s;0.17)

Model II

Lobar* −0.02 (−0.09;0.05) −0.03 (−0.09;0.04) −0.02 (−0.09;0.05) −0.02 (−0.11;0.08) −0.05 (−0.16;0.06)
 Single 0.002 (−0.08;0.08) −0.01 (−0.07;0.05) 0.001 (−0.07;0.07) 0.01 (−0.08;0.10) −0.03 (−0.16;0.09)
 2–4 CMBs 0.002 (−0.14;0.14) 0.03 (−0.08;0.13) 0.02 (−0.09;0.14) −0.02 (−0.18;0.14) −0.10 (−0.32;0.12)
 >4 CMBs −0.35 (−0.62;−0.07) −0.29 (−0.49;−0.09) −0.41 (−0.63;−0.19) −0.34 (−0.65;−0.04) −0.07 (−0.49;0.35)

Deep or infratentorial± −0.003 (−0.12;0.11) −0.02 (−0.13;0.09) 0.02 (−0.09;0.14) 0.02 (−0.14;0.17) 0.04 (−0.14;0.22)
 Single CMB 0.04 (−0.11;0.18) 0.02 (−0.09;0.13) 0.06 (−0.06;0.18) −0.02 (−0.18;0.14) 0.10 (−0.12;0.32)
 2–4 CMBs 0.08 (−0.15;0.32) −0.02 (−0.19;0.16) 0.07 (−0.12;0.26) 0.21 (−0.05;0.46) 0.29 (−0.08;0.65)
 >4 CMBs −0.29 (−0.57;−0.002) −0.16 (−0.37;0.06) −0.22 (−0.45;0.02) −0.14 (−0.45;0.18) −0.56 (−1.00;−0.11)

Model III

Lobar* −0.02 (−0.09;0.05) −0.03 (−0.09;0.04) −0.01 (−0.09;0.06) −0.02 (−0.12;0.08) −0.05 (−0.16;0.06)
 Single −0.01 (−0.09;0.07) −0.02 (−0.08;0.04) 0.01 (−0.06;0.07) 0.01 (−0.08;0.10) −0.04 (−0.16;0.09)
 2–4 CMBs −0.01 (−0.16;0.13) 0.02 (−0.08;0.13) 0.03 (−0.09;0.14) −0.03 (−0.19;0.13) −0.10 (−0.33;0.12)
 >4 CMBs −0.29 (−0.57;0.002) −0.24 (−0.45;−0.03) −0.40 (−0.62;−0.17) −0.28 (−0.60;0.04) −0.01 (−0.43;0.42)

Deep or infratentorial± 0.03 (−0.09;0.15) 0.02 (−0.10;0.13) 0.04 (−0.08;0.16) 0.05 (−0.11;0.21) 0.08 (−0.10;0.27)
 Single CMB 0.04 (−0.11;0.18) 0.02 (−0.09;0.13) 0.05 (−0.07;0.17) −0.01 (−0.17;0.15) 0.10 (−0.12;0.32)
 2–4 CMBs 0.10 (−0.14;0.33) −0.01 (−0.18;0.17) 0.08 (−0.12;0.27) 0.23 (−0.03;0.49) 0.31 (−0.05;0.67)
 >4 CMBs −0.13 (−0.45;0.20) 0.006 (−0.24;0.25) −0.17 (−0.44;0.10) −0.05 (−0.41;0.32) −0.48 (−0.98;0.03)

Values represent differences in Z-score of various cognitive domains in those with microbleeds compared to those without microbleeds.

Model I: adjusted for age, sex, education level, baseline domain tests scores, and time between baseline and follow-up visit.

Model II: as Model I, additionally adjusted for APOE ε4 carriership and a propensity score of cardiovascular risk factors which included hypertension, total and HDL cholesterol, smoking status, diabetes mellitus, lipid-lowering and antithrombotic medication use.

Model III: as Model I, additionally for lacunes, intracranial volume, white matter lesion volume.

The following neuropsychological tests were included for G-factor: Stroop interference, LDST, WFT, delayed WLT, Purdue Pegboard; for executive functions: Stroop interference, LDST, WFT; for information processing: Stroop reading and naming, LDST; for memory: immediate and delayed WLT; for motor Speed: Purdue Pegboard.

*

Lobar microbleeds with or without cerebellar microbleeds.

±

Deep or infratentorial microbleeds with or without lobar microbleeds.